Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2008-01-08
2008-01-08
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S742000, C424S776000, C514S001000, C514S169000
Reexamination Certificate
active
07316820
ABSTRACT:
The present invention relates to the discovery of a transdermal delivery system that can deliver high molecular weight pharmaceuticals and cosmetic agents to skin cells. A novel transdermal delivery system with therapeutic and cosmetic application and methods of use of the foregoing is disclosed.
REFERENCES:
patent: 5318960 (1994-06-01), Toppo
patent: 5431924 (1995-07-01), Ghosh et al.
patent: 5472713 (1995-12-01), Fein et al.
patent: 5571671 (1996-11-01), Potter
patent: 5614212 (1997-03-01), D'Angelo et al.
patent: 5665378 (1997-09-01), Davis et al.
patent: 5708038 (1998-01-01), Davis
patent: 5716625 (1998-02-01), Hahn et al.
patent: 5744368 (1998-04-01), Goldgaber et al.
patent: 5837853 (1998-11-01), Takashima et al.
patent: 5840746 (1998-11-01), Ducharme et al.
patent: 5849334 (1998-12-01), Rivlin
patent: 5861268 (1999-01-01), Tang et al.
patent: 5885597 (1999-03-01), Botknecht et al.
patent: 5891651 (1999-04-01), Roche et al.
patent: 5891857 (1999-04-01), Holt et al.
patent: 5958384 (1999-09-01), Holick
patent: 6103246 (2000-08-01), Tisdale et al.
patent: 6444234 (2002-09-01), Kirby et al.
patent: 6759056 (2004-07-01), Jordan
patent: 6787152 (2004-09-01), Kirby et al.
patent: 6946144 (2005-09-01), Jordan
patent: 2003/0104040 (2003-06-01), Kirby et al.
patent: 2004/0170676 (2004-09-01), Jordan
patent: 2004/0202709 (2004-10-01), Kirby et al.
patent: 2005/0019384 (2005-01-01), Jordan
patent: 2006/0188532 (2006-08-01), Jordan
patent: 2006/0193901 (2006-08-01), Jordan
patent: WO 92/08470 (1992-05-01), None
patent: WO 97/09992 (1997-03-01), None
patent: WO 98/03163 (1998-01-01), None
patent: WO 98/33474 (1998-08-01), None
patent: WO 98/34629 (1998-08-01), None
Aloe Laboratories. Manufacturing Procedures. Product: Regular Traditional Hand Fillet Aloe Vera Juice: 1 page.
Amadio, et al. 1993. Nonsteroidal anti-inflammatory drugs.Postgraduate Medicine, 93(4):73-97.
Barel and Clarys. 1995. Study of the Stratum Corneum Function by Transepidermal Water Loss Measurements: Comparison between Two Commercial Instruments.Skin Pharmacol, 8:186-195.
Biomedical Information Services Ltd. 1996. Inspection Criteria. General Standard for Testing Purity of Aloe Vera: 7 pages.
Bronaugh and Collier. 1991. In Vitro Percutaneous Absorption Studies:Principle, Fundamentals, and Applications, eds., Bronaugh and Malibach, Boca Rator, Fl. CRC Press, pp. 237-241.
Chattem Inc. 1999. Packaging-Flexall QuickGel.
Cohen, et al. 1992. Wound Healing/Biochemical and Clinical Aspects, 1sted. WB Saunders, Philadelphia.
Collier et al. 1989. Maintenance of Skin Viability during in Vitro Percutanous Absorption/Metabolism Studies.Toxicology and Applied Pharmacology, 99:522-533.
Croda, “Guide to specialty ingredients for the personal care industry,” pp. i-iii and 1-42 (2000).
Cummings, et al., “A natural alternative: Jojoba esters are a new category of naturally derived, oil free emollients that offer good properties for a wide variety of cosmetic products,” SPC Asia, (May 1999): 4 pages.
Cummings, et al., “In a nutshell,”; 3 pages.
Downing et al. 1993. Dermatology in General Medicine. Fitzpatrick, et al., eds., pp. 210-221.
Esoteric Oils (Pty), “Macadamia oil for massage therapy and to help moisturize the skin,” http:///www.essentialoils.co.za/macadamia—oil.htm, pp. 1-3, (May 5, 2004).
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® 20: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® 30: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® 60: 1 page
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® 70: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORASOLVS® PEG-10 Sunflower: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORASUN® 90, Refined, Bleached, Winterized, Deodorized: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® IPJ: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® HIPJ: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORABEADS®, JOJOBA 40/60: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORABEADS®, JOJOBA White 60/100: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORASOLVS® PEG-80 Jojoba: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORASOLVS® PEG-120 Jojoba: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® Jojoba Oil, Pasteurized, Not Refined: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORAESTERS® 15: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORABEADS®, JOJOBA 28/60, 1 of 2: 1 page.
FLORAESTERS® International Flora Technologies. Product Specification for FLORABEADS®, JOJOBA 28/60, 2 of 2: 1 page.
Grindlay and Reynold. 1986. The Aloe Vera Phenomenon: A Review of the Properties and Modern Uses of the Leaf Parenchyma Gel.J. of Ethnopharmacology, 16:117-151.
Hart, et al. 1988. Two Functionally and Chemically Distinct Immunomodulatory Compounds in the Gel of Aloe Vera.J. of Ethnopharmacology, 23:61-71.
Hirata, et al. 1977. Biologically Active Constituents of Leaves and Roots of Aloe Arborescens var. Natalensis.Z. Naturforsch, 32c:731-734.
http://www.botanical.com/botanical/mgmh/f/gtanki31.html.
http://www.natplus.com/products/productNumber=7124.
International Aloe Science Council, Inc. The Datasheet-100% Pure Aloe Vera: 1 page.
International Search Report from PCT/US99/15409 dated Jan. 13, 2000.
Melaslow™, Brightening Cream with Melaslow™, SC-306, product formula: 2 pages.
Melaslow™, Skin Lightening Age Spot Treatment, product specification and claim substantiation: 2 pages.
Nelson, et al. 1991. Mid-Infrared Laser Ablation of Stratum Corneum Enhanves in Vitro Percutaneous Transport of Drugs.The Society for Investigative Dermatology, Inc.:878-879.
O'Malley, P. et al., “Emu Products, Increasing Production and Profitability,”Rural Industruies and Development Corporation, pp. i-110, Dec. 1999.
Ponec, M. 1994, Epidermal Lipids in Vivo.The Keratinocyte Handbook, Leigh, et al., eds., pp. 351-363.
Sederma, Etioline, product brochure, pp. 1-16 (Oct. 1996).
Sederma, Ichtyocollagene, product brochure, pp. 1-19 (Aug. 1993).
Sederma, Matrixyl “The physiological reconstruction of the matrix structures of the dermis to reduce deep and medium wrinkles: tested in vivo on a panel of 35 subjects during 2-4-6 months,” product brochure, synopsis and pp. 1-44 (Sep. 1999).
Sederma, Melaslow™ “Lightens the complexion/Decreases age spots,” product brochure, overview and pp. 1-28 (Dec. 2000).
Taguchi, et al., “Enhancement of propylene glycol distribution in the skin by high puritycis-unsaturated fatty acids with different alkyl chain lengths having different double bond position,” Biol. Pharm. Bull., vol. 22, No. 4, pp. 407-411 (1999).
Woodin, L. 1993. Cutting Postop Pain.RN, Aug. 26-33.
George Konata M.
JRX Biotechnology, Inc.
Knobbe Martens Olson & Bear LLP
Richter Johann
LandOfFree
Mixture for transdermal delivery of low and high molecular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixture for transdermal delivery of low and high molecular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixture for transdermal delivery of low and high molecular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2786638